Increased chemoreceptor output and ventilatory response to sustained hypoxia

Area of Science:

• Physiology
• Respiratory Control
• Neuroscience

Background:

• The human ventilatory response to sustained hypoxia (VRSH) is biphasic: an initial increase from peripheral chemoreceptors followed by a central hypoxic depression.
• Understanding the role of peripheral chemoreceptors in this pattern is crucial for respiratory control research.

Purpose of the Study:

• To investigate the impact of selectively stimulating peripheral chemoreceptors on the biphasic VRSH pattern.
• To evaluate the ventilatory response to hypoxia after pretreatment with almitrine, a known peripheral chemoreceptor stimulant.

Main Methods:

• Eight subjects underwent a single-blind study with almitrine (75 mg) or placebo pretreatment.
• Ventilatory responses were measured during sequential exposure to room air, oxygen, and sustained hypoxia (SaO2 = 80%) with constant end-tidal CO2.
• Inspiratory minute ventilation and breathing patterns were analyzed during different phases of the protocol.

Main Results:

• The VRSH remained biphasic regardless of pretreatment.
• Almitrine pretreatment significantly amplified the initial ventilatory increase during hypoxia compared to placebo (14.2 vs. 4.6 L/min).
• The subsequent decline in ventilation during hypoxia was also significantly greater after almitrine administration.

Conclusions:

• Selective peripheral chemoreceptor stimulation with almitrine potentiates both the initial and subsequent phases of the ventilatory response to sustained hypoxia.
• This suggests a significant role for peripheral chemoreceptor drive in modulating the overall pattern of the human hypoxic ventilatory response.